Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 26
Filter
1.
Int J Radiat Biol ; 94(7): 671-677, 2018 07.
Article in English | MEDLINE | ID: mdl-29893613

ABSTRACT

PURPOSE: Broomrape produces serious damage to many legume crops and, particularly, becomes a limiting factor for faba bean (Vicia faba L.) production in the Mediterranean basin. Currently, several traditional methods of control have been developed, but none has proved to be effective for this parasite. However, breeding for resistance to this pest remains as one of the most feasible and environment-friendly methods for managing broomrape, but the mechanisms governing the interaction between the parasite and the host are not yet well understood. Therefore, we studied the behavior and molecular and enzymatic changes associated with the resistance to Orobanche foetida in faba bean mutants, which were obtained through radiation mutagenesis. MATERIALS AND METHODS: Three faba bean genotypes were used in this study, the variety 'Badï', characterized by high productivity in Orobanche-free soils and susceptibility to O. foetida, and two mutant lines P2M3 and P7M3 (derived from radio mutagenesis program), selected for their higher resistance to O. foetida in a field evaluation. The infection progress and the relative changes in the co-culture response, the enzymatic activities changes and the efficiency of the root extract stimulants from the host plant were followed and evaluated in all the genotypes. RESULTS: Experiments showed that low induction of seed germination is a major component of resistance in these lines against O. foetida. This is confirmed by the in vitro experiments with root exudates. The parallel reduction in infection was accompanied by the continuous enhancement of the peroxidase activity, the polyphenol oxidase activity and the phenylalanine ammonia lyase activity in faba bean roots. CONCLUSION: These data suggest the contribution of these enzymes in faba bean resistance to O. foetida broomrape induced by the use of gamma rays. Management of Orobanche by way of crop selection, based on these enzyme systems is a possible option.


Subject(s)
Orobanche/physiology , Plant Weeds/physiology , Vicia faba/genetics , Genotype , Germination , Mutagenesis , Plant Breeding , Plant Roots , Vicia faba/enzymology , Vicia faba/radiation effects
2.
Afr Health Sci ; 17(2): 346-355, 2017 Jun.
Article in English | MEDLINE | ID: mdl-29062329

ABSTRACT

BACKGROUND: The dissemination of extended-spectrum ß-lactamase (ESBL)-producing bacteria presented a great concern worldwide. Gram-negative organisms such as Escherichia coli and Klebsiella pneumoniae are the most frequently isolated pathogens responsible for nosocomial infections. OBJECTIVES: The aim of this study was to investigate and to follow the emergence of resistance and the characterization of Extended-Spectrum Beta-Lactamases (ESBL) among broad-spectrum beta-lactam-Escherichia coli clinical isolates recovered from the military hospital and Habib Thameur hospital in Tunisia. METHODS: A total of 113 E.coli isolates obtained during the period 2004 through 2012 showed a significant degree of multi-resistance. Among these strains, the double-disk synergy test confirmed the ESBL phenotype in 46 isolates. These included 32(70%) strains from Hospital A and 14(30%) from Hospital B. RESULTS: The ESBL was identified as CTX-M-15. The ESBL resistance was transferred by a 60 kb plasmid CTXM-15-producing isolates were unrelated according to the PFGE analysis and characterization of the regions surrounding the blaCTX-M-15 showed the ISEcp1 elements located in the upstream region of the bla gene and 20 of them truncated by IS26. CONCLUSION: ESBL producing E. coli strains are a serious threat in the community in Tunisia and we should take into consideration any possible spread of such epidemiological resistance.


Subject(s)
Escherichia coli Infections/drug therapy , Escherichia coli/drug effects , beta-Lactam Resistance/genetics , Anti-Bacterial Agents/therapeutic use , Cross Infection/drug therapy , Cross Infection/epidemiology , Cross Infection/microbiology , Disk Diffusion Antimicrobial Tests , Drug Resistance, Multiple, Bacterial/genetics , Electrophoresis, Polyacrylamide Gel , Escherichia coli/genetics , Escherichia coli Infections/epidemiology , Escherichia coli Infections/microbiology , Escherichia coli Proteins/genetics , Humans , Polymerase Chain Reaction , Tunisia/epidemiology , beta-Lactamases/genetics
3.
Acta Biochim Pol ; 63(3): 581-7, 2016.
Article in English | MEDLINE | ID: mdl-27382647

ABSTRACT

As part of the contribution to the global efforts in research of thermostable enzymes being of industrial interest, we focus on the isolation of thermophilic bacteria from Tunisian hot springs. Among the collection of 161 strains of thermophilic Bacillus isolated from different samples of thermal water in Tunisia, 20% are capable of growing at 100°C and the rest grow at 70°C or above. Preliminary activity tests on media supplemented with enzyme-substrates confirmed that 35 strains produced amylases, 37 - proteases, 43 - cellulases, 31 - xylanases and 37 - mannanases. The study of the effect of temperature on enzyme activity led to determination of the optimal temperatures of activities that vary between 60 and 100°C. Several enzymes were active at high temperatures (80, 90 and 100°C) and kept their activity even at 110°C. Several isolated strains producing enzymes with high optimal temperatures of activity were described for the first time in this study. Both strains B62 and B120 are producers of amylase, protease, cellulase, xylanase, and mannanase. The sequencing of 16S DNA identified isolated strains as Geobacillus kaustophillus, Aeribacillus pallidus, Geobacillus galactosidasus and Geobacillus toebii.


Subject(s)
Bacillus/enzymology , Bacterial Proteins/biosynthesis , Geobacillus/enzymology , Amylases/biosynthesis , Amylases/chemistry , Bacillus/genetics , Bacterial Proteins/chemistry , Cellulase/biosynthesis , Cellulase/chemistry , Endopeptidases/biosynthesis , Endopeptidases/chemistry , Enzyme Stability , Geobacillus/genetics , Hot Springs/microbiology , Hot Temperature , Molecular Typing , Phylogeny , RNA, Ribosomal, 16S , Tunisia , Water Microbiology , Xylosidases/biosynthesis , Xylosidases/chemistry
4.
Biomed Res Int ; 2016: 9178962, 2016.
Article in English | MEDLINE | ID: mdl-27069928

ABSTRACT

A new thermostable, haloalkaline, solvent stable SDS-induced serine protease was purified and characterized from a thermophilic Geobacillus toebii LBT 77 newly isolated from a Tunisian hot spring. This study reveals the potential of the protease from Geobacillus toebii LBT 77 as an additive to detergent with spectacular proprieties described for the first time. The protease was purified to homogeneity by ammonium sulfate precipitation followed by Sephadex G-75 and DEAE-Cellulose chromatography. It was a monomeric enzyme with molecular weight of 30 kDa. The optimum pH, temperature, and NaCl for maximum protease activity were 13.0, 95°C, and 30%, respectively. Activity was stimulated by Ca(2+), Mg(2+), DTNB, ß-mercaptoethanol, and SDS. The protease was extremely stable even at pH 13.25, 90°C, and 30% NaCl and in the presence of hydrophilic, hydrophobic solvents at high concentrations. The high compatibility with ionic, nonionic, and commercial detergents confirms the utility as an additive to cleaning products. Kinetic and thermodynamic characterization of protease revealed K m = 1 mg mL(-1), V max = 217.5 U mL(-1), K cat/K m = 99 mg mL(-1) S(-1), E a = 51.5 kJ mol(-1), and ΔG (⁎) = 56.5 kJ mol(-1).


Subject(s)
Bacterial Proteins/chemistry , Bacterial Proteins/isolation & purification , Geobacillus/enzymology , Serine Proteases/chemistry , Serine Proteases/isolation & purification , Bacterial Proteins/metabolism , Enzyme Stability , Hot Temperature , Organic Chemicals , Serine Proteases/metabolism , Surface-Active Agents
5.
Pest Manag Sci ; 72(12): 2330-2338, 2016 Dec.
Article in English | MEDLINE | ID: mdl-26997099

ABSTRACT

BACKGROUND: Some radiation-mutagenised chickpea mutants potentially resistant to the broomrape, Orobanche foetida Poir., were selected through field trials. The objectives of this work were to confirm resistance under artificial infestation, in pots and mini-rhizotron systems, and to determine the developmental stages of broomrape affected by resistance and the relevant resistance mechanisms induced by radiation mutagenesis. RESULTS: Among 30 mutants tested for resistance to O. foetida, five shared strong resistance in both pot experiments and mini-rhizotron systems. Resistance was not complete, but the few individuals that escaped resistance displayed high disorders of shoot development. Results demonstrated a 2-3-fold decrease in stimulatory activity of root exudates towards broomrape seed germination in resistant mutants in comparison with non-irradiated control plants and susceptible mutants. Resistance was associated with an induction of broomrape necrosis early during infection. When infested, most of the resistant mutants shared enhanced levels of soluble phenolic contents, phenylalanine ammonia lyase activity, guaiacol peroxidase activity and polyphenol oxidase activity, in addition to glutathione and notably ascorbate peroxidase gene expression in roots. CONCLUSION: Results confirmed enhanced resistance in chickpea radiation-mutagenised mutants, and demonstrated that resistance is based on alteration of root exudation, presumed cell-wall reinforcement and change in root oxidative status in response to infection. © 2016 Society of Chemical Industry.


Subject(s)
Cicer/genetics , Orobanche/physiology , Plant Weeds/physiology , Biomarkers , Catechol Oxidase/metabolism , Cicer/physiology , Cicer/radiation effects , Germination , Mutagenesis/radiation effects , Peroxidase/metabolism , Phenotype , Plant Exudates/pharmacology , Plant Roots/physiology , Seeds/growth & development
6.
J Biomed Sci ; 22: 27, 2015 Apr 11.
Article in English | MEDLINE | ID: mdl-25888770

ABSTRACT

BACKGROUND: ESBL-producing bacteria are a clinical problem in the management of diseases caused by these pathogens. Worldwide, systemic infections with BL enzymes are evolving by mutations from classical bla genes in an intensified manner and they continue to be transferred across species. RESULTS: E.cloacae BF1417 isolate and its transconjugants gave positive results with the DDST, suggesting the presence of ESBL. Sequence analysis revealed a bla SHV-ESBL-type gene that differs from the gene encoding SHV-1 by five point mutations resulting in three amino acid substitutions in the coding region: C123R, I282T and L286P. This novel SHV-type enzyme was designated SHV-128. The conjugation tests and plasmid characterization showed that the bla SHV-128 is located on a conjugative plasmid IncFII type. Expression studies demonstrated that the above mutations participated in drug resistance, hydrolysis of extended spectrum ß-lactam and the change of the isoelectric point of the protein. CONCLUSION: These findings underscore the diversity by which antibiotic resistance can arise and the evolutionary potential of the clinically important ESBL enzymes. In addition, this study highlights the need for systematic surveillance of ESBL-mediated resistance as well as in clinical areas and communities.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Enterobacter cloacae/drug effects , Enterobacter cloacae/genetics , beta-Lactam Resistance , beta-Lactamases/genetics , beta-Lactams/pharmacology , Bacterial Proteins/metabolism , Base Sequence , Enterobacter cloacae/metabolism , Microbial Sensitivity Tests , Molecular Sequence Data , Polymerase Chain Reaction , Sequence Alignment , beta-Lactamases/metabolism
7.
Diagn Microbiol Infect Dis ; 81(1): 50-2, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25315769

ABSTRACT

The aim of this study is to report the emergence of IncA/C conjugative plasmids harboring blaTEM-24, blaDHA-1, qnrA6, and aac(6')-Ib-cr genes among Providencia spp. isolates recovered in 2008 in Tunisia. The double-disk synergy test confirmed the phenotype extended-spectrum ß-lactamase (ESBL) in 2 Providencia stuartii and 5 Providencia rettgeri. These ESBLs were coresistant to cefoxitin, chloramphenicol, ofloxacin, and sulfonamides but remained susceptible to imipenem. Three ß-lactamases TEM-2, TEM-24, and DHA-1 were detected. blaTEM-24, blaDHA-1, aac(6')-Ib-cr, and qnrA6 genes were successfully transferred to Escherichia coli strain HB101, and they were found located on the conjugatifs IncA/C plasmids. Genetic relatedness showed similar and different patterns among P. stuartii and P. rettgeri strains, respectively.


Subject(s)
Cross Infection/microbiology , Enterobacteriaceae Infections/microbiology , Providencia/drug effects , Providencia/genetics , beta-Lactamases/genetics , Bacterial Proteins/genetics , Cross Infection/drug therapy , Enterobacteriaceae Infections/drug therapy , Genes, Bacterial , Hospitals , Humans , Microbial Sensitivity Tests , Plasmids/genetics , Providencia/isolation & purification , Providencia/pathogenicity , Treatment Outcome , Tunisia
8.
Int J Microbiol ; 2014: 548656, 2014.
Article in English | MEDLINE | ID: mdl-24949015

ABSTRACT

Klebsiella pneumoniae ML2011, a multiresistant isolate, was isolated from the Military Hospital of Tunis (Tunisia). The determination of the minimal inhibitory concentrations exhibited by K. pneumoniae ML2011 was performed by Etest. The crude extract of the isolates contains four different ß -lactamases with pI 5.5, 7.3, 7.6, and 8.6. Only the ß -lactamases with pI 7.3 and pI 8.6 were transferred by transformation and conjugation experiment. Molecular characterization of these genes was performed by PCR and sequencing. The chromosomal ß -lactamases are TEM (pI 5.5) and SHV-1 (7.6). CTX-M-28 (pI 8.6) and the novel variant of SHV named SHV-104 (pI 7.3) were encoded by bla gene located on a 50 kb highly conjugative plasmid. The SHV-104 ß -lactamase was produced in E. coli and purified. Its profile of activity was determined. Compared to SHV-1, SHV-104 contains one mutation, R202S. Their kinetic parameters were similar except for cefotaxime. The analysis of the predicted structure of SHV-104 indicated that the R202S mutation suppresses a salt bridge present in SHV-1. Therefore, the overall flexibility of the protein increased and might improve the hydrolysis of cefotaxime. We can conclude that the multiresistant phenotype of K. pneumoniae ML2011 strain is mainly linked to the production of CTX-M-28 since SHV-104 possesses a narrow spectrum of activity.

9.
Braz J Infect Dis ; 18(2): 211-4, 2014.
Article in English | MEDLINE | ID: mdl-24378226

ABSTRACT

A clinical Providencia stuartii isolate SM662 was recovered from a patient hospitalized in the intensive care unit at the Military hospital, Tunisia. This isolate was resistant to penicillins, cephalosporins, aminoglycosides and fluoroquinolones. A marked in vitro synergy between ceftazidime or cefotaxime and amoxicillin-clavulanic acid on Mueller-Hinton agar plates suggested the presence of an extended-spectrum-ß-lactamase. In addition, an unusual synergy was found between cefepime or aztreonam, and cefoxitin or imipenem on a double disk synergy test suggesting a VEB-type extended-spectrum-ß-lactamase. The characterization of ß-lactamases and associated resistance genes was performed by isoelectric focusing, polymerase chain reaction and nucleotide sequencing. Two ß-lactamases bands with pI values of 5.4 and 7.7, which were matched to TEM-1, VEB-1-a and OXA-2-like ß-lactamases were detected. The blaVEB-1-a gene was found to be associated with complex genetic structures, including Re elements. These ß-lactamases were not transferred by electroporation or conjugation experiments to the transconjugants and electroporants. Hybridization methods showed that the extended-spectrum-ß-lactamase encoding gene may have a chromosomal localization. The isolate SM662 produced the quinolone resistance determinants qnrA6 and aac(6')-Ib-cr which were successfully transferred. The detection of an associated chromosomal quinolone resistance revealed the presence of a gyrA mutation at codon 83 (Ser83Ile). This is the first report of the linkage VEB-1-a/OXA-2-like in P. stuartii associated with the description of qnrA6 and aac(6')-Ib-cr genes in this isolate.


Subject(s)
Anti-Bacterial Agents/pharmacology , Providencia/drug effects , Providencia/enzymology , beta-Lactamases/genetics , Drug Resistance, Multiple, Bacterial , Electrophoresis, Gel, Pulsed-Field , Escherichia coli Proteins , Humans , Intensive Care Units , Male , Middle Aged , Polymerase Chain Reaction , Providencia/classification , Providencia/genetics , Tunisia
10.
Scand J Infect Dis ; 45(8): 600-5, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23746343

ABSTRACT

OBJECTIVES: The aim of this study was to investigate the prevalence and the emergence of plasmid-mediated quinolone resistance among broad-spectrum beta-lactam-resistant Proteus mirabilis and Morganella morganii clinical isolates recovered in the Military Hospital in Tunisia. METHODS: Of 200 strains examined, 50 exhibited resistance to quinolones. Quinolone resistance determinants (qnr and aac(6')-Ib-cr) were characterized by multiplex PCR and sequencing. Chromosomal quinolone resistance mutations in the quinolone resistance-determining region (QRDR) and class 1 integron characterization were analysed by PCR and sequencing. The clonal relationship between the isolates was studied by pulsed-field gel electrophoresis (PFGE). RESULTS: Fourteen isolates harboured qnrA6 and among them 8 (57%) were extended-spectrum beta-lactamase (ESBL) producers, whilst 12 (85%) isolates harboured blaDHA-1. Mutations in the QRDR were detected in gyrA (Ser83Ile, Glu87Lys), gyrB (Ser464Phe), and parC (Ser80Ile). qnrA6 and blaDHA-1 genes were found embedded in complex sul1-type class 1 integrons. A gene cassette carrying aac(6')-Ib-cr was found located in the class 1 integron upstream of the qacEΔ1 gene. According to the PFGE analysis, the isolates were clonally unrelated. CONCLUSIONS: This is the first description in North Africa of class 1 integrons carrying blaDHA-1, qnrA6 gene, and aac(6')-Ib-cr determinants in clinical strains of Proteus mirabilis and Morganella morganii.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Enterobacteriaceae Infections/microbiology , Genes, Bacterial , Morganella morganii/genetics , Proteus mirabilis/genetics , Quinolones/pharmacology , Adult , Aged , DNA, Bacterial/genetics , Electrophoresis, Gel, Pulsed-Field , Female , Hospitals, Military , Humans , Integrons , Male , Middle Aged , Molecular Typing , Morganella morganii/classification , Morganella morganii/drug effects , Morganella morganii/isolation & purification , Plasmids , Polymerase Chain Reaction , Proteus mirabilis/classification , Proteus mirabilis/drug effects , Proteus mirabilis/isolation & purification , Sequence Analysis, DNA , Tunisia , beta-Lactams/pharmacology
11.
J Med Microbiol ; 61(Pt 9): 1286-1289, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22683657

ABSTRACT

This study investigated the genetic environment of bla(CTX-M) genes and associated resistance genes in seven Proteus mirabilis and six Morganella morganii extended spectrum ß-lactamase (ESBL)-positive isolates. The isolates were recovered from hospitalized patients with respiratory or urinary tract infections at the Military Hospital of Tunis, Tunisia. Twenty-one of the 200 strains exhibited non-susceptibility to third generation cephalosporins and, among these strains, the double-disk synergy test confirmed the ESBL phenotype in 13 isolates. These ESBL producers were co-resistant to chloramphenicol, tetracycline and oflaxacin but remained susceptible to ertapenem (MIC<0.25 mg l(-1)). The presence and nature of bla(CTX-M-15), bla(CTX-M-8), bla(TEM-24), bla(TEM-1) and bla(TEM-2) genes was determined by PCR and sequencing. Chromosomal localization of the bla(CTX-M-15) gene was confirmed in all strains, with the exception of M. morganii isolate M-17991, by Southern-blot analysis performed either on chromosomal or plasmid DNA. M. morganii M-12012 and M. morganii M-6019 showed the same PFGE pattern, whereas the remaining CTX-M-15-producing isolates were unrelated. The presence of ISEcp1 was ascertained in CTX-M-15-producing isolates. A class 1 integron with different gene cassettes (dfrA1, orfC and aadB) was found in five P. mirabilis and six M. morganii isolates.


Subject(s)
Chromosomes, Bacterial/genetics , DNA Transposable Elements/genetics , Enterobacteriaceae Infections/epidemiology , Hospitals, Military/statistics & numerical data , Morganella morganii/enzymology , Proteus mirabilis/enzymology , beta-Lactamases/genetics , Anti-Bacterial Agents/pharmacology , DNA, Bacterial/genetics , Enterobacteriaceae Infections/microbiology , Humans , Microbial Sensitivity Tests , Morganella morganii/drug effects , Morganella morganii/genetics , Morganella morganii/isolation & purification , Polymerase Chain Reaction , Proteus mirabilis/drug effects , Proteus mirabilis/genetics , Proteus mirabilis/isolation & purification , Tunisia/epidemiology , beta-Lactams/pharmacology
12.
Clin Res Hepatol Gastroenterol ; 35(11): 750-4, 2011 Nov.
Article in English | MEDLINE | ID: mdl-21652277

ABSTRACT

BACKGROUND: The change of the way of life and the food practices in Tunisia due inter alia to the improvement of the socioeconomic conditions induced low fuel consumption of food with significant nutritional interest such as those rich in food fibres which have positive effects on the reduction and the prevention of some complications of the metabolic diseases such as the obesity whose prevalence among Tunisian women is increasingly high. OBJECTIVE: We assessed the association between the mean daily fiber intake and anthropometric parameters, the serum lipid profile and the serum glucose concentration among urban Tunisian women. METHODS: We conducted a 7-day food weighing method among 260 women of which 60 are obese (BMI > 30 kg/m(2)). The weighing method was done by trained and experienced workers in the National Institute of Nutrition of Tunisia. All the results were treated with the (Bilnut) software (1991 version) to which a list of 235 special Tunisian foods was added. We calculated their mean daily fiber intake and we prospectively evaluated the correlations between it and the BMI, the waist circumference, total plasma cholesterol, HDL-cholesterol, triglyceridemia and glycaemia. RESULTS: Obese women are found to consume less fiber than non-obese women (21.73 ± 3.25 g/day vs 26.25 ± 2.7 g/day; P<0.0001). Very high and significant correlations were observed between dietary fiber intake and the parameters investigated: BMI (r=-0.709, P<0.0001), waist circumference (r=-0.790; P<0.0001), total plasma cholesterol (r=-0.488; P<0.0001), triglyceridemia (r=-0.741; P<0.0001) and glycaemia (r=-0.557, P<0.0001). However, we find a positive but a non significant correlation with the HDL-cholesterol and the mean daily fiber intake (r=0.309; P=0.02). CONCLUSIONS: This study provides additional support to the inverse association between fiber consumption and weight gain, the serum lipid profiles, the glycaemia and the waist circumference. Our findings emphasizes the relevance of increased the intakes of fiber from varied sources that may help avoid weight gain among obese adults.


Subject(s)
Body Mass Index , Diet , Dietary Fiber/administration & dosage , Waist Circumference , Adult , Blood Glucose/analysis , Cholesterol/blood , Female , Humans , Middle Aged , Prospective Studies , Triglycerides/blood , Tunisia , Urban Health
13.
Microb Drug Resist ; 15(3): 195-9, 2009 Sep.
Article in English | MEDLINE | ID: mdl-19728777

ABSTRACT

Klebsiella pneumoniae ML1708 exhibited a multiresistance phenotype, including resistance to all beta-lactams tested, chloramphenicol, ciprofloxacin, nalidixic acid, tetracycline, and streptomycin. The double-disk synergy test was positive. ML1708 harbored a 50 kb conjugative plasmid that encoded a beta-lactamase of pI 5.5. The corresponding bla gene was identified by polymerase chain reaction and sequencing as a bla(TEM) gene. The deduced protein sequence revealed a new variant of TEM-1 beta-lactamase designated TEM-164. TEM-164 contains the unusual following mutations: L40V and I279T. These modifications may result in a change of the pI to 5.5 and hydrolyze cefotaxime and ceftazidime.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Multiple, Bacterial , Klebsiella Infections/epidemiology , Klebsiella pneumoniae/drug effects , beta-Lactamases/classification , beta-Lactams/pharmacology , Conjugation, Genetic , Humans , Klebsiella Infections/microbiology , Klebsiella pneumoniae/enzymology , Klebsiella pneumoniae/genetics , Microbial Sensitivity Tests , Molecular Sequence Data , Mutation , Sequence Analysis, DNA , Tunisia/epidemiology , beta-Lactam Resistance , beta-Lactamases/genetics
14.
C R Biol ; 330(8): 565-70, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17637436

ABSTRACT

A clinical isolate of Escherichia coli LBT04 was found to have a high-level resistance to broad-spectrum beta-lactams. Analysis of this strain by the disk diffusion test revealed synergies between clavulanic acid and ceftazidime, cefotaxime. Clavulanic acid decreased the MICs of ceftazidime, cefotaxime, and ceftriaxone, which suggested that LBT04 produced an extended-spectrum beta-lactamase. These resistances were carried by a 1080-bp chromosomal gene that encoded a beta-lactamase with a pI of 6.3. Cloning and sequencing experiments showed that this beta-lactamase revealed identity with the bla(TEM-1) gene encoding the TEM-1 beta-lactamase, except for a replacement of the Glu residue at position 104 by Lys, and of the Gly residue at position 238 by Ser. These two mutations were encountered in TEM-15 beta-lactamase, but this is the first description of this enzyme in the E. coli species in Tunisian hospitals.


Subject(s)
Cefotaxime/pharmacology , Ceftazidime/pharmacology , Drug Resistance, Bacterial , Escherichia coli Infections/epidemiology , Escherichia coli/drug effects , beta-Lactamases/metabolism , Anti-Bacterial Agents/pharmacology , Blotting, Southern , DNA, Viral/genetics , DNA, Viral/isolation & purification , Disease Outbreaks , Escherichia coli/enzymology , Escherichia coli/genetics , Escherichia coli/isolation & purification , Gene Amplification , Humans , Inpatients , Microbial Sensitivity Tests , Polymerase Chain Reaction , Tunisia/epidemiology , beta-Lactamases/genetics
15.
Microb Drug Resist ; 13(2): 114-8, 2007.
Article in English | MEDLINE | ID: mdl-17650963

ABSTRACT

Klebsiella pneumoniae CH0905 strain exhibiting high-level cefotaxime resistance was isolated from a stool culture in the intensive care unit. The resistance gene responsible was shown to be located on a conjugative 60-kb plasmid designated pCH0905. The minimum inhibitory concentration (MIC) values for cefotaxime and ceftazidime of the original isolate and the transconjugates were 256 mug/ml. Isoelectric focusing of a protein preparation from the K. pneumoniae strain showed beta-lactamases with the pI values of 7.6 and 6.3. A 1,080-bp fragment amplified with PCR was cloned into the pGEM-T Easy vector. The nucleotide sequence of the complete 1,080 bp was determined. Sequence analysis revealed that the bla(TEM) gene of pCH0905 differed from bla(TEM-1) by two mutations, leading to the following amino acid substitutions: the glutamic acid residue at position 104 by lysine and the glycine residue at position 238 by serine (Ambler numbering). The association of these two mutations was described previously in TEM-15 beta-lactamase, but this is the first detection of this enzyme in Tunisia.


Subject(s)
Anti-Bacterial Agents/pharmacology , Klebsiella pneumoniae/drug effects , beta-Lactamases/genetics , Amino Acid Sequence , Base Sequence , Cefotaxime/pharmacology , Drug Resistance, Bacterial , Intensive Care Units , Klebsiella pneumoniae/enzymology , Klebsiella pneumoniae/isolation & purification , Microbial Sensitivity Tests , Molecular Sequence Data , Polymerase Chain Reaction , Tunisia
16.
Diagn Microbiol Infect Dis ; 58(4): 459-63, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17449209

ABSTRACT

Escherichia coli CA0210 was identified in a stool culture of a 03-month-neonate in Tunisia. This strain was resistant to beta-lactams, including ureidopenicillins, ticarcillin-clavulanic acid, cefpirome, ceftazidime, and cefotaxime, but it remained susceptible to imipenem and cefoxitin. The beta-lactam-hydrolyzing beta-lactamase gene of E. coli CA0210 and the upstream and downstream regions were cloned, sequenced, and expressed in E. coli DH5alpha. These resistances were carried by a 1080-bp chromosomal gene that encoded a beta-lactamase with a pI of 6.3. Cloning and sequencing experiments showed that the corresponding blaTEM-15 gene was part of a chromosomally located Tn801 transposon.


Subject(s)
Escherichia coli Infections/microbiology , Escherichia coli/drug effects , Escherichia coli/genetics , beta-Lactam Resistance/genetics , beta-Lactamases/genetics , Base Sequence , Cloning, Molecular , DNA Transposable Elements , Escherichia coli/isolation & purification , Escherichia coli Proteins/chemistry , Escherichia coli Proteins/genetics , Feces/microbiology , Humans , Infant , Isoelectric Point , Microbial Sensitivity Tests , Molecular Sequence Data , Sequence Analysis, DNA , beta-Lactamases/chemistry , beta-Lactams/pharmacology
17.
Biochem Cell Biol ; 85(1): 49-55, 2007 Feb.
Article in English | MEDLINE | ID: mdl-17464344

ABSTRACT

Bleomycin is a highly potent cytotoxic and genotoxic agent used in the chemotherapy of various types of tumors. It is a radiomimetic anticancer drug that produces single- and double-stranded DNA breaks in a catalytic way. Using Saccharomyces cerevisiae as a model system, we show that when a high amount of bleomycin molecules is internalized (100 micromol/L), morphological changes identical to those usually associated with apoptosis, i.e., a sub-G1 region peak, chromatin condensation, and very rapid DNA fragmentation into oligonucleosomal-sized fragments, are observed. The known bleomycin inhibitors cobalt and EDTA were able to prevent bleomycin nucleasic activity and thus apoptotic cell death. However, both oligomycin, a potent inhibitor of the mitochondrial F0F1-ATPase, and antimycin, a drug affecting mitochondria respiration, were unable to prevent the bleomycin-induced apoptotic-like cell death. These results suggest that high bleomycin concentrations induce an apoptosis-like mitochondria-independent cell death in yeast.


Subject(s)
Antibiotics, Antineoplastic/pharmacology , Apoptosis/physiology , Bleomycin/pharmacology , Mitochondria/drug effects , Saccharomyces cerevisiae/drug effects , Antimycin A/analogs & derivatives , Antimycin A/pharmacology , Apoptosis/drug effects , Chromatin Assembly and Disassembly/drug effects , Chromatin Assembly and Disassembly/physiology , DNA Fragmentation , Edetic Acid/pharmacology , Oligomycins/pharmacology
18.
Environ Mol Mutagen ; 47(9): 707-17, 2006 Dec.
Article in English | MEDLINE | ID: mdl-17078097

ABSTRACT

The Saccharomyces cerevisiae SPT10 protein possesses a DNA-binding domain that is fused to a putative histone acetyltransferase domain. It binds specifically to upstream-activating sequence elements in the core histone promoters and plays a direct role in histone gene regulation. SPT10 is also required for cell-cycle-specific K56 acetylation at histone genes, allowing the recruitment of the nucleosome remodeling factor Snf5 and subsequent regulation of gene transcription. We reisolated the SPT10 gene in a functional genome-wide screen designed to identify haploid yeast mutants that are hypersensitive to the antitumor drug bleomycin, which acts by damaging DNA. In addition to bleomycin, we show that spt10Delta mutants are also hypersensitive to a limited set of genotoxic agents that create DNA strand breaks, but not to 254-nm ultraviolet light or 4-nitroquinoline-1-oxide, which generate helix distortion. The hypersensitivities of the spt10Delta mutant to the genotoxic agents are rescued by a single copy plasmid carrying the SPT10 gene. We further showed that spt10Delta mutants displayed a modest twofold increase spontaneous mutant frequency, as compared to the parent. Following exposure to bleomycin, these mutants accumulate unrepaired lesions, e.g., DNA strand breaks with blocked 3'-ends in the chromosomal DNA. This defect is not due to the altered expression level or the enzymatic activities of a key DNA repair enzyme, APN1, which is known to repair DNA strand breaks with blocked ends. We propose that SPT10 mediates repair of a subset of DNA lesions by acetylating histones to promote recruitment of DNA repair enzymes.


Subject(s)
Mutagens/toxicity , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae/drug effects , Transcription Factors/genetics , 4-Nitroquinoline-1-oxide/toxicity , Bleomycin/toxicity , Chromatin/genetics , DNA Damage , DNA Repair , Gamma Rays/adverse effects , Histone Acetyltransferases , Hydrogen Peroxide/toxicity , Methyl Methanesulfonate/toxicity , Phleomycins/toxicity , Quinolones/toxicity , Rad51 Recombinase/genetics , Saccharomyces cerevisiae/genetics , Ultraviolet Rays/adverse effects
19.
Antimicrob Agents Chemother ; 50(9): 3183-5, 2006 Sep.
Article in English | MEDLINE | ID: mdl-16940125

ABSTRACT

A novel natural TEM beta-lactamase with extended-spectrum activity, TEM-138, was identified in a ceftazidime-resistant clinical isolate of Salmonella enterica serovar Infantis. Compared to TEM-1, TEM-138 contains the following mutations: E104K, N175I, and G238S. The bla(TEM-138) gene was located on a 50-kb transferable plasmid. Expression studies with Escherichia coli revealed efficient ceftazidimase and cefotaximase activities for TEM-138.


Subject(s)
Salmonella enterica/enzymology , beta-Lactamases/metabolism , Base Sequence , Ceftazidime/pharmacology , Cephalosporin Resistance , Humans , Kinetics , Microbial Sensitivity Tests , Molecular Sequence Data , Salmonella enterica/drug effects , Salmonella enterica/isolation & purification
20.
Appl Biochem Biotechnol ; 125(3): 189-99, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15917582

ABSTRACT

Various strains of Escherichia coli, isolated from different patients, were screened for type II restriction endonuclease activity. In 1 out of 23 patients, a type II restriction endonuclease activity was found. The restriction endonuclease designated Eco1524I was purified to near homogeneity, based on hydroxyapatite and heparin sepharose chromatography. Eco1524I exhibited endonuclease restriction activity in the pH range from 6.0 to 10.0 (maximum level at pH 8.0) and required Mg2+ as divalent cation. The enzyme was stable till temperature 55 degrees C and pH range from 6.0 to 10.0. Eco1524I recognized the sequence 6-bp palindromic 5'AGG downward arrow CCT 3', producing blunt end and is found to be an isoschizomer of Stu I.


Subject(s)
DNA/chemistry , Deoxyribonucleases, Type II Site-Specific/chemistry , Escherichia coli/enzymology , Escherichia coli/isolation & purification , Binding Sites , Deoxyribonucleases, Type II Site-Specific/isolation & purification , Enzyme Activation , Enzyme Stability , Escherichia coli/classification , Hydrogen-Ion Concentration , Protein Binding , Species Specificity , Temperature
SELECTION OF CITATIONS
SEARCH DETAIL
...